Literature DB >> 21057846

Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice.

Kazunori Fujiwara1, Kazuyuki Kitatani, Kei Fukushima, Hiroaki Yazama, Hisanori Umehara, Mitsunori Kikuchi, Yasuyuki Igarashi, Hiroya Kitano, Toshiro Okazaki.   

Abstract

BACKGROUND: Sphingolipids, components of cellular membranes in eukaryotic cells, have roles in the regulation of tumor growth, inflammation, angiogenesis, and immunity. We investigated the effects of dietary glucosylceramides, sphingolipids isolated from rice bran, on tumor growth of human head and neck squamous cell carcinoma.
METHODS: The tumor cell line SCCKN cells isolated from well-differentiated human head and neck cancer were subcutaneously inoculated into the right flank of NOD/SCID mice, to establish an SCCKN xenograft model. Rice bran glucosylceramides (300 mg/kg/day) were administered orally to the mice for 14 consecutive days.
RESULTS: Dietary glucosylceramides significantly inhibited the growth of the xenograft tumor in comparison with the control group. The TUNEL stain revealed that treatment of mice with glucosylceramides increased the number of apoptotic cells in the implanted tumor tissues and that apoptosis induction was accompanied by the formation of active/cleaved caspase-3.
CONCLUSION: These results suggest that dietary glucosylceramides possibly exert anti-tumor activity by inducing apoptosis of head and neck squamous cell carcinoma. Therefore, their potential usefulness in treatment and prevention of human head and neck squamous cell carcinoma warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057846     DOI: 10.1007/s10147-010-0141-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  26 in total

Review 1.  Nasopharyngeal cancer and the Southeast Asian patient.

Authors:  C Her
Journal:  Am Fam Physician       Date:  2001-05-01       Impact factor: 3.292

2.  Inhibitory effect of dietary monoglucosylceramide 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats.

Authors:  Morihiko Inamine; Masumi Suzui; Takamitsu Morioka; Tatsuya Kinjo; Tatsuya Kaneshiro; Tomoko Sugishita; Tadashi Okada; Naoki Yoshimi
Journal:  Cancer Sci       Date:  2005-12       Impact factor: 6.716

3.  Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro.

Authors:  S Ishihara; M Nieda; J Kitayama; T Osada; T Yabe; A Kikuchi; Y Koezuka; S A Porcelli; K Tadokoro; H Nagawa; T Juji
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

Review 4.  Glycolipids as immune modulatory tools.

Authors:  Gadi Lalazar; Sarah Preston; Ehud Zigmond; Ami Ben Yáacov; Yaron Ilan
Journal:  Mini Rev Med Chem       Date:  2006-11       Impact factor: 3.862

Review 5.  Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.

Authors:  A H Merrill; E M Schmelz; D L Dillehay; S Spiegel; J A Shayman; J J Schroeder; R T Riley; K A Voss; E Wang
Journal:  Toxicol Appl Pharmacol       Date:  1997-01       Impact factor: 4.219

6.  Dietary glucosylceramide improves skin barrier function in hairless mice.

Authors:  Kiyomi Tsuji; Susumu Mitsutake; Junko Ishikawa; Yutaka Takagi; Masashi Akiyama; Hiroshi Shimizu; Takahiro Tomiyama; Yasuyuki Igarashi
Journal:  J Dermatol Sci       Date:  2006-09-26       Impact factor: 4.563

7.  Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice.

Authors:  D L Dillehay; S K Webb; E M Schmelz; A H Merrill
Journal:  J Nutr       Date:  1994-05       Impact factor: 4.798

8.  Programmed cell death induced by ceramide.

Authors:  L M Obeid; C M Linardic; L A Karolak; Y A Hannun
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Tumor specific cytotoxicity of beta-glucosylceramide: structure-cytotoxicity relationship and anti-tumor activity in vivo.

Authors:  Hirosuke Oku; Changchun Li; Masayuki Shimatani; Hironori Iwasaki; Takayoshi Toda; Takafumi Okabe; Hisami Watanabe
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-23       Impact factor: 3.333

Review 10.  The sphingolipid salvage pathway in ceramide metabolism and signaling.

Authors:  Kazuyuki Kitatani; Jolanta Idkowiak-Baldys; Yusuf A Hannun
Journal:  Cell Signal       Date:  2007-12-14       Impact factor: 4.315

View more
  7 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Glucosylceramide Changes Bacterial Metabolism and Increases Gram-Positive Bacteria through Tolerance to Secondary Bile Acids In Vitro.

Authors:  Huanghuang Dai; Akira Otsuka; Kurumi Tanabe; Teruyoshi Yanagita; Jiro Nakayama; Hiroshi Kitagaki
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

3.  Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide.

Authors:  Hiroaki Yazama; Kazuyuki Kitatani; Kazunori Fujiwara; Misaki Kato; Mayumi Hashimoto-Nishimura; Katsuyuki Kawamoto; Kensaku Hasegawa; Hiroya Kitano; Alicja Bielawska; Jacek Bielawski; Toshiro Okazaki
Journal:  Int J Clin Oncol       Date:  2014-08-01       Impact factor: 3.402

4.  C6-ceramide Inhibits the Motility of Anaplastic Thyroid Carcinoma Cells.

Authors:  Kazunori Fujiwara; Hiroaki Yazama; Ryohei Donishi; Satoshi Koyama; Takahiro Fukuhara; Kazuyuki Kitatani; Hideyuki Kataoka; Hiromi Takeuchi
Journal:  Yonago Acta Med       Date:  2020-03-23       Impact factor: 1.641

5.  Inhibitory Effects of Glucosylceramide on Tumorigenesis Induced by a Carcinogen in Mice.

Authors:  Kazunori Fujiwara; Hiroaki Yazama; Ryouhei Donishi; Satoshi Koyama; Takahiro Fukuhara; Hiromi Takeuchi
Journal:  Laryngoscope       Date:  2019-12-06       Impact factor: 3.325

6.  The impact of sphingosine kinase-1 in head and neck cancer.

Authors:  Paulette M Tamashiro; Hideki Furuya; Yoshiko Shimizu; Kayoko Iino; Toshihiko Kawamori
Journal:  Biomolecules       Date:  2013-08-12

7.  Japanese traditional dietary fungus koji Aspergillus oryzae functions as a prebiotic for Blautia coccoides through glycosylceramide: Japanese dietary fungus koji is a new prebiotic.

Authors:  Hiroshi Hamajima; Haruka Matsunaga; Ayami Fujikawa; Tomoya Sato; Susumu Mitsutake; Teruyoshi Yanagita; Koji Nagao; Jiro Nakayama; Hiroshi Kitagaki
Journal:  Springerplus       Date:  2016-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.